These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33816762)

  • 1. Prevention of cognitive decline in subjective cognitive decline APOE ε4 carriers after EGCG and a multimodal intervention (PENSA): Study design.
    Forcano L; Fauria K; Soldevila-Domenech N; Minguillón C; Lorenzo T; Cuenca-Royo A; Menezes-Cabral S; Pizarro N; Boronat A; Molinuevo JL; de la Torre R;
    Alzheimers Dement (N Y); 2021; 7(1):e12155. PubMed ID: 33816762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment.
    McMaster M; Kim S; Clare L; Torres SJ; D'Este C; Anstey KJ
    Clin Interv Aging; 2018; 13():2397-2406. PubMed ID: 30538436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol.
    Barbera M; Lehtisalo J; Perera D; Aspö M; Cross M; De Jager Loots CA; Falaschetti E; Friel N; Luchsinger JA; Gavelin HM; Peltonen M; Price G; Neely AS; Thunborg C; Tuomilehto J; Mangialasche F; Middleton L; Ngandu T; Solomon A; Kivipelto M;
    Alzheimers Res Ther; 2024 Jan; 16(1):23. PubMed ID: 38297399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memory support training and lifestyle modifications to promote healthy aging in persons at risk for Alzheimer's disease: a digital application supported intervention (Brain Boosters).
    Tomaszewski Farias S; Fox J; Dulaney H; Chan M; Namboodiri S; Harvey DJ; Weakley A; Rahman S; Luna C; Beech BF; Campbell L; Schmitter-Edgecombe M
    BMC Geriatr; 2023 Dec; 23(1):881. PubMed ID: 38129775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.
    Donohue MC; Sperling RA; Salmon DP; Rentz DM; Raman R; Thomas RG; Weiner M; Aisen PS; ; ;
    JAMA Neurol; 2014 Aug; 71(8):961-70. PubMed ID: 24886908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle Risk Factors and Cognitive Outcomes from the Multidomain Dementia Risk Reduction Randomized Controlled Trial, Body Brain Life for Cognitive Decline (BBL-CD).
    McMaster M; Kim S; Clare L; Torres SJ; Cherbuin N; DʼEste C; Anstey KJ
    J Am Geriatr Soc; 2020 Nov; 68(11):2629-2637. PubMed ID: 32909259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating a multimodal lifestyle intervention with medical food in prodromal Alzheimer's disease: the MIND-AD
    Thunborg C; Wang R; Rosenberg A; Sindi S; Andersen P; Andrieu S; Broersen LM; Coley N; Couderc C; Duval CZ; Faxen-Irving G; Hagman G; Hallikainen M; Håkansson K; Kekkonen E; Lehtisalo J; Levak N; Mangialasche F; Pantel J; Rydström A; Stigsdotter-Neely A; Wimo A; Ngandu T; Soininen H; Hartmann T; Solomon A; Kivipelto M
    Alzheimers Res Ther; 2024 May; 16(1):118. PubMed ID: 38812047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial.
    Solomon A; Turunen H; Ngandu T; Peltonen M; Levälahti E; Helisalmi S; Antikainen R; Bäckman L; Hänninen T; Jula A; Laatikainen T; Lehtisalo J; Lindström J; Paajanen T; Pajala S; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Soininen H; Kivipelto M
    JAMA Neurol; 2018 Apr; 75(4):462-470. PubMed ID: 29356827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactive Effects of Apolipoprotein E ε4 and Triiodothyronine on Memory Performance in Patients With Subjective Cognitive Decline.
    Lee JS; Soh Y; Kim HG; Lee KM; Kwon YN; Yoon SS; Park KC; Rhee HY
    Front Med (Lausanne); 2020; 7():298. PubMed ID: 32671080
    [No Abstract]   [Full Text] [Related]  

  • 11. The Effects of Subjective Cognitive Decline on APOE Genotype Disclosure in the Butler Hospital Alzheimer's Prevention Registry.
    Lee AKW; Collier MK; Thompson LI; Popescu D; Arthur E; Correia S; Salloway SP; Alber J
    J Prev Alzheimers Dis; 2023; 10(2):152-161. PubMed ID: 36946441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers.
    Sun Y; Wang X; Wang Y; Dong H; Lu J; Scheininger T; Ewers M; Jessen F; Zuo XN; Han Y
    Alzheimers Res Ther; 2019 Jun; 11(1):50. PubMed ID: 31159873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Coaching for Cognition in Alzheimer's (COCOA) trial: Study design.
    Roach JC; Hara J; Fridman D; Lovejoy JC; Jade K; Heim L; Romansik R; Swietlikowski A; Phillips S; Rapozo MK; Shay MA; Fischer D; Funk C; Dill L; Brant-Zawadzki M; Hood L; Shankle WR
    Alzheimers Dement (N Y); 2022; 8(1):e12318. PubMed ID: 35910672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mid-to-Late Life Healthy Lifestyle Modifies Genetic Risk for Longitudinal Cognitive Aging among Asymptomatic Individuals.
    Xu Y; Sun Z; Jonaitis E; Deming Y; Lu Q; Johnson SC; Engelman CD
    medRxiv; 2024 May; ():. PubMed ID: 38853902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.
    Bransby L; Lim YY; Ames D; Fowler C; Roberston J; Harrington K; Snyder PJ; Villemagne VL; Salvado O; Masters CL; Maruff P
    J Clin Exp Neuropsychol; 2019 Aug; 41(6):591-600. PubMed ID: 30924399
    [No Abstract]   [Full Text] [Related]  

  • 17. Neural correlates of subjective cognitive decline in adults at high risk for Alzheimer's disease.
    Ben-Ami L; Ravona-Springer R; Tsarfaty G; Raizman R; Shumacher A; Sharvit-Ginon I; Greenbaum L; Bendlin BB; Okun E; Heymann A; Schnaider Beeri M; Livny A
    Front Aging Neurosci; 2023; 15():1067196. PubMed ID: 36819726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Web-Based Intervention Effects on Mild Cognitive Impairment Based on Apolipoprotein E Genotype: Quasi-Experimental Study.
    Tsolaki AC; Tsolaki M; Pandria N; Lazarou E; Gkatzima O; Zilidou V; Karagianni M; Iakovidou-Kritsi Z; Kimiskidis VK; Bamidis PD
    J Med Internet Res; 2020 May; 22(5):e14617. PubMed ID: 32379048
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.